Bullet proof is just an analogy here.
In any randomized
Bullet proof is just an analogy here.
In any randomized trail, there is always a factor of luck. In CD12, we got unlucky so that relatively more 65 year old/older patients in the treatment group (2:1 ratio treatment/placebo), so the efficacy of the drug looks bad without doing age adjusting analysis.
We could have gotten super lucky in CD12, having relatively more 65 year old/older patients in placebo group making the efficacy of the drug looks stronger than its real efficacy. But that didn't happen.
Since we already know that the age group distribution could be a factor of luck for it could potentially negatively impact our trial outcome, we can introduce age stratification in the randomization process so that age group distribution is equal in treatment/placebo groups.
The age stratification effort is to eliminate age as a factor to skew efficacy test outcome negatively/favorably. The effort is to make the trial result more trustworthy. So it is not a process of shoot first then put the target where the bullet hit.
There could be other unknown factors for any trials. To eliminate/mitigate those unknown factors, one way is to have a huge trial size to reduce the effect of luck.
5
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A New Chapter for a Seasoned Leader When a high flyer like Stephanie Knepp steps into a new arena, you know folks are going to sit up and pay attention. This time, she's making waves by joining the Exceptional Women Alliance (EWA), a heavy-hitting community of women leaders. With her extensive background in scaling businesses and empowering leaders, she's bound to bring...
Continue Reading
Troubles Mount for Qfin Holdings Well, you don't need a crystal ball to see this storm brewing for Qfin Holdings, Inc. (NASDAQ:QFIN). On the heels of a nasty 18.91% nosedive in their stock price, a class action lawsuit is looming overhead like a mischievous cloud ready to rain on investors' parades. It's the kind of legal and financial brew that could leave shareholders...
Continue Reading
HEMI V8 Legacy Reinvention at SEMA 2026 If you're the sort who gets their hands greasy restoring or revamping classic muscle, well, Direct Connection just made your life a whole lot easier. Stellantis' performance arm pulled the wraps off not just one, but six new HEMI V8 crate engine packages at the 2026 SEMA Show. Now, that's how you turn heads in Vegas. A New...
Continue Reading
What's Brewing with Lumentum and Marvell? There's no denying the chatter on Wall Street when there's a potential shake-up, especially with a big merger at stake. We're staring down the barrel of an investigation concerning Lumentum Holdings Inc. (NASDAQ: LITE) and Marvell Technology, Inc.'s deal. The M&A Class Action Firm, helmed by Juan Monteverde, is the name leading...
Continue Reading
Not Your Average Tech Buzz It starts with Hollywood glitz and an unexpected dance partner. The PrimeBOT, a Chinese personal robot, is ditching the drab tech corner and seeping into mainstream culture. Imagine Johnny Depp slapping some paint on this machine alongside local kids. Now, picture the Kardashians casually dining with it, letting it join their lunchtime...
Continue Reading
Synova and Eventus: A Powerful Partnership If you've ever traded a share or two, you know the name of the game is risk management. Step into Synova Global's latest move, and you'll see a gamble worth watching closely. This time around, Synova has tapped Eventus to bring their Validus trade surveillance platform into the fold. Now, Eventus and its star player, Validus,...
Continue Reading
Moberg Pharma's Fresh U.S. Patent: A Game Changer? Moberg Pharma just snagged a U.S. patent for their whiz-bang dosing of MOB-015. Yup, the FDA’s go-ahead is still out of reach, but this patent is like hitting a full house on the river—sweetening the pot significantly. It's all about onychomycosis, or nail fungus, if you're not up on your medical terms. With patent...
Continue Reading
Unpacking Corporate Technologies' Offer It's not every day a company doles out free consultations, but Corporate Technologies is doing just that. They're tossing New Jersey's small-to-mid businesses a lifeline with free IT and cybersecurity assessments. There's no catch, just thirty minutes of pure, no-nonsense evaluation of your tech setup. Couldn’t hurt to know where...
Continue Reading
MEDICA 2026: Wincomm and Portwell Join Forces November's got one heck of an event lined up with MEDICA 2026, where Wincomm and Portwell are teaming up to showcase what they've got up their sleeves in medical AI computing. This whole shebang runs from November 16 to 19, with their setup in Hall 12, Stand C76, Düsseldorf, Germany. But why should investors care? Because...
Continue Reading
The Future of Drug Development: AI's New Role When it comes to pharmaceutical R&D, Some outfits are playing pin the tail on the donkey, but Differentia Bio over here is sharpening the pin with some futuristic gadgetry. Yep, they're jazzing up the game with AI-powered digital twins, building lifelike disease environments that predict therapeutic outcomes with precision...
Continue Reading
Top 5 Most Recently Viewed Articles
Building Transparency Collaborates with KieranTimberlake In a significant stride towards enhancing sustainability in the building sector, Building Transparency has announced its collaboration with KieranTimberlake to develop Tally 2.0, an innovative advancement of the tallyLCA tool. This partnership aims to provide insights into the environmental impact of building...
Continue Reading
Stellar's Exclusive Thanksgiving Mega Bundle Announcement The renowned leader in data recovery solutions, Stellar, has introduced an exciting Thanksgiving Mega Bundle that captures the attention of both professionals and everyday users. For a limited time, you can acquire eight premium software utilities for just $39.45, representing a staggering 90% discount from the...
Continue Reading
FuelPositive's Commitment to Sustainable Agriculture FuelPositive Corporation is making notable progress in sustainable agriculture thanks to its innovative Green Ammonia production technology. The Company’s goal is to empower farmers while reducing their dependence on conventional fertilizers, seamlessly blending innovation with ecological responsibility. Their latest...
Continue Reading
Alfred I. duPont Charitable Trust Welcomes New Leadership In a significant shift within its leadership, the Alfred I. duPont Charitable Trust has announced the appointment of Thomas G. Kuntz as the new chairman. This transition comes as Hugh Durden, the long-standing chairman, retires from active service to take on an Emeritus role after nearly three decades of dedicated...
Continue Reading
QuoteMedia Set to Release Q3 Financial Results QuoteMedia, Inc. (OTCQB: QMCI), a prominent name in the market data and financial applications sector, is gearing up to unveil its financial performance for the third quarter of 2025. Investors and stakeholders can mark their calendars for November 14, when detailed results will be disclosed. Details of the Upcoming...
Continue Reading